Evaluation of Treatment Satisfaction in Children With an Allergy and Who Received an Antihistamine

Completed

• Conditions: Allergies

• Registration Number: NCT00453583
• Lead Sponsor: UCB Pharma

Brief Summary

This is a non-interventional retrospective data collection study from children aged from 2 to 12 years old diagnosed with an allergy and who received a treatment consisting of an H1-antihistamine. The period of last taken medication will be observed to evaluate the global satisfaction of the parents and physician for this last treatment.

Detailed Description

Not available

Study Timeline

• Study Start: 2007-03
• Study First Submitted: 2007-03-28
• Study First Submitted QC: 2007-03-28
• Study First Posted: 2007-03-29
• Primary Completion: 2008-01
• Study Completion: 2008-01
• Status Verified: 2012-05
• Last Update Submitted: 2013-12-13
• Last Update Posted: 2013-12-16

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 4581

Inclusion Criteria

• Children from 2-12 included
• History of allergy
• Used an Antihistamine within market authorization

Exclusion Criteria

• Child not yet treated for the presented allergy

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Parent satisfaction on a 11-point scale	duration of the study

Secondary Outcome Measures

Name	Time	Method
Physician satisfaction on an 11-point scale	duration of the study
Efficacy, tolerability and global satisfaction	duration of the study

Trial Locations

Locations (1)

UCB Pharma; 🇺🇸 Smyrna, Georgia, United States